Literature DB >> 6202880

Protective effect of biological response modifiers on murine cytomegalovirus infection.

K Ebihara, Y Minamishima.   

Abstract

Pretreatment with two biological response modifiers (BRM), OK-432 and PS-K, protected mice from lethal infection by murine cytomegalovirus (MCMV). This was evidenced by an increase in 50% lethal doses and a decrease in titers of infectious viruses replicated in the liver and spleen. Spleen cells from the BRM-treated mice augmented the natural killer (NK) cell activity and suppressed the replication of MCMV in vitro. During MCMV infection, the NK cell activity of the spleen cells was maintained at a high level in the BRM-treated mice, whereas it was severely impaired in untreated mice. The BRM-induced protection was nullified by concomitant administration of antiasialo GM1 antibody. Interferon was neither induced by BRM treatment nor enhanced in BRM-pretreated and MCMV-infected mice. Thus, the protective effect of OK-432 and PS-K seems to be based on activation of NK cells and prevention of MCMV-induced inhibition of the NK cell activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202880      PMCID: PMC254408     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Cytotoxic T lymphocyte response to murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz; F A Ennis
Journal:  Nature       Date:  1978-06-15       Impact factor: 49.962

2.  Effect of concurrent cytomegaloviral infection and undernutrition on the growth and immune response of mice.

Authors:  J R Cruz; J L Waner
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

3.  The role of macrophages in mice infected with murine cytomegalovirus.

Authors:  C A Mims; J Gould
Journal:  J Gen Virol       Date:  1978-10       Impact factor: 3.891

4.  Immunosuppression during acute murine cytomegalovirus infection.

Authors:  J E Osborn; A A Blazkovec; D L Walker
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

5.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

6.  New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.

Authors:  M Torisu; M Katano; Y Kimura; H Itoh; M Takesue
Journal:  Surgery       Date:  1983-03       Impact factor: 3.982

7.  Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients.

Authors:  T Hattori; M Niimoto; T Koh; A Nakano; M Oride; W Takiyama; K Nishimawari
Journal:  Jpn J Surg       Date:  1979-06

8.  Role of T lymphocytes in recovery from murine cytomegalovirus infection.

Authors:  S E Starr; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

9.  Murine model for immunoprophylaxis of cytomegalovirus infection. I. Efficacy of immunization.

Authors:  Y Minamishima; Y Eizuru; A Yoshida; R Fukunishi
Journal:  Microbiol Immunol       Date:  1978       Impact factor: 1.955

10.  Mouse strain difference in the expression of antitumor activity of PS-K.

Authors:  C Yoshikumi; K Nomoto; K Matsunaga; T Fuji; K Takeya
Journal:  Gan       Date:  1975-12
View more
  21 in total

1.  Postnatal porencephaly induced in mouse by murine cytomegalovirus.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; C Kadota; M Nagahama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.

Authors:  Jian-Ming Li; Lauren Southerland; Mohammad S Hossain; Cynthia R Giver; Ying Wang; Kasia Darlak; Wayne Harris; James Waschek; Edmund K Waller
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

3.  Susceptibility of W/WV mice to murine cytomegalovirus infection.

Authors:  T Ohashi; Y Nawa; Y Minamishima; M Owhashi
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Granulocyte-macrophage colony-stimulating factor enhances the production of eosinophil chemotactic lymphokine by egg-associated granulomas of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

5.  Murine cytomegalovirus infection of cultured mouse embryos.

Authors:  Y Tsutsui; I Naruse
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

6.  Susceptibility of brain cells to murine cytomegalovirus infection in the developing mouse brain.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; M Nagahama; A Mizutani; I Naruse
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Susceptibility of mouse embryo to murine cytomegalovirus infection in early and mid-gestation stages.

Authors:  A Kashiwai; N Kawamura; C Kadota; Y Tsutsui
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Microphthalmia and cerebral atrophy induced in mouse embryos by infection with murine cytomegalovirus in midgestation.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; C Kadota
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

9.  Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K.

Authors:  E Yefenof; E Einat; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection.

Authors:  Y Tsutsui; A Kashiwai; N Kawamura; S Aiba-Masago; I Kosugi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.